NAFARELIN | NAFARELIN | ATC H01CA02
HORMONES TREATMENT OF CENTRAL PRECOCIOUS PUBERTY (CPP) GONADOTROPIN-RELEASING HORMONE AGONIST | NASAL | Cmax 1.36 NANOMOLAR Tmax 0.4 HOUR F 2.8 PERCENT PPB 80 PERCENT HT 3 HOUR | GONADOTROPIN-RELEASING HORMONE RECEPTOR GONADOTROPIN-RELEASING HORMONE II RECEPTOR | Gonadotropin-releasing hormone receptor UNIPROT P30968 GNRHR more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |